Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 262

1.

Impact of Negative Symptoms on Quality of Life in Patients with Schizophrenia.

Novick D, Montgomery W, Cheng Y, Moneta V, Haro JM.

Value Health. 2015 Nov;18(7):A836-7. doi: 10.1016/j.jval.2015.09.351. Epub 2015 Oct 20. No abstract available.

PMID:
26534468
2.

Health-related quality of life in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in a naturalistic outpatient setting.

Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM.

Patient Prefer Adherence. 2015 Oct 16;9:1481-90. doi: 10.2147/PPA.S89870. eCollection 2015.

3.

Duloxetine for the treatment of painful diabetic peripheral neuropathy in Venezuela: economic evaluation.

Carlos F, Espejel L, Novick D, López R, Flores D.

Medwave. 2015 Sep 25;15(8):e6265. doi: 10.5867/medwave.2015.08.6265. English, Spanish.

PMID:
26460688
4.
5.

Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.

Carter GC, King DT, Hess LM, Mitchell SA, Taipale KL, Kiiskinen U, Rajan N, Novick D, Liepa AM.

J Med Econ. 2015 Nov;18(11):954-66. doi: 10.3111/13696998.2015.1066380. Epub 2015 Sep 11.

PMID:
26212479
6.

Methadone Medical Maintenance: An Early 21st-Century Perspective.

Novick DM, Salsitz EA, Joseph H, Kreek MJ.

J Addict Dis. 2015;34(2-3):226-37. doi: 10.1080/10550887.2015.1059225.

PMID:
26110221
7.

Which somatic symptoms are associated with an unfavorable course in Chinese patients with major depressive disorder?

Novick D, Montgomery WS, Aguado J, Peng X, Brugnoli R, Haro JM.

Asia Pac Psychiatry. 2015 Dec;7(4):427-35. doi: 10.1111/appy.12189. Epub 2015 Jun 5.

PMID:
26047023
8.

Caregiving for patients with Alzheimer's disease or dementia and its association with psychiatric and clinical comorbidities and other health outcomes in Brazil.

Laks J, Goren A, Dueñas H, Novick D, Kahle-Wrobleski K.

Int J Geriatr Psychiatry. 2016 Feb;31(2):176-85. doi: 10.1002/gps.4309. Epub 2015 May 25.

PMID:
26011093
9.

Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?

Novick D, Montgomery W, Moneta MV, Peng X, Brugnoli R, Haro JM.

Int J Psychiatry Clin Pract. 2015;19(3):174-81. doi: 10.3109/13651501.2015.1031681. Epub 2015 May 7.

PMID:
25946899
10.

Should Unexplained Painful Physical Symptoms be Considered within the Spectrum of Depressive Symptoms?

Hong J, Novick D, Montgomery W, Aguado J, Dueñas H, Peng X, Haro JM.

Clin Pract Epidemiol Ment Health. 2015 Mar 31;11:130-9. doi: 10.2174/1745017901511010130. eCollection 2015.

11.

Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.

Hong J, Novick D, Montgomery W, Moneta MV, Dueñas H, Peng X, Haro JM.

Asia Pac Psychiatry. 2015 Mar 24. doi: 10.1111/appy.12178. [Epub ahead of print]

PMID:
25808275
12.

Antidepressant medication treatment patterns in Asian patients with major depressive disorder.

Novick D, Montgomery W, Moneta V, Peng X, Brugnoli R, Haro JM.

Patient Prefer Adherence. 2015 Mar 11;9:421-8. doi: 10.2147/PPA.S68432. eCollection 2015.

13.

Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study.

Novick D, Hong J, Montgomery W, Dueñas H, Gado M, Haro JM.

Neuropsychiatr Dis Treat. 2015 Jan 22;11:197-205. doi: 10.2147/NDT.S75498. eCollection 2015.

14.

Impact of painful physical symptoms on depression outcomes in elderly Asian patients.

Novick D, Montgomery W, Bertsch J, Peng X, Brugnoli R, Haro JM.

Int Psychogeriatr. 2014 Nov 4:1-8. [Epub ahead of print]

PMID:
25366979
15.
16.

Symptomatic remission and patient quality of life in an observational study of schizophrenia: is there a relationship?

Haro JM, Novick D, Perrin E, Bertsch J, Knapp M.

Psychiatry Res. 2014 Dec 15;220(1-2):163-9. doi: 10.1016/j.psychres.2014.07.034. Epub 2014 Aug 15.

PMID:
25194449
17.

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection.

Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H.

Neuropsychiatr Dis Treat. 2014 Jun 20;10:1125-31. doi: 10.2147/NDT.S61409. eCollection 2014.

18.

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Peng X, Sun P, Novick D, Andrews J, Sun S.

J Pain Res. 2014 Jan 9;7:37-46. doi: 10.2147/JPR.S51636. eCollection 2014.

19.

Heparanase interacts with resistin and augments its activity.

Novick D, Barak S, Ilan N, Vlodavsky I.

PLoS One. 2014 Jan 21;9(1):e85944. doi: 10.1371/journal.pone.0085944. eCollection 2014.

20.

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.

Andrews JS, Wu N, Chen SY, Yu X, Peng X, Novick D.

J Pain Res. 2013 Nov 26;6:825-35. doi: 10.2147/JPR.S50323. eCollection 2013.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk